Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

Zuzana Walker1, Emilio Moreno2, Alan Thomas2

  • 1From University College London (Z.W.); North Essex Partnership University NHS Foundation Trust (Z.W., T.S., T.W.), Braintree; GE Healthcare (E.M.), Buckinghamshire; Newcastle University (A.T.), Newcastle upon Tyne; Glasgow Memory Clinic Ltd. (F.I.); Brighton and Sussex Medical School (N.T.), Brighton, UK; Centre for Age-Related Diseases (D.A.), Stavanger University Hospital; Department of Geriatric Psychiatry (D.A.), Akershus University Hospital, Oslo, Norway; Department of Neurobiology, (D.A.) Care Sciences and Society Division of Alzheimer's Disease Research Centre, Karolinska Institutet, Stockholm, Sweden; Karl Landsteiner Institut für Gedächtnis und Alzheimerforschung Wien (M.R.), Austria; and University of Brescia (A.P.), Italy. z.walker@ucl.ac.uk.

Neurology
|August 12, 2016
PubMed
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
660
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K